MX2022013928A - Proceso de elaboracion de espiroderivados. - Google Patents

Proceso de elaboracion de espiroderivados.

Info

Publication number
MX2022013928A
MX2022013928A MX2022013928A MX2022013928A MX2022013928A MX 2022013928 A MX2022013928 A MX 2022013928A MX 2022013928 A MX2022013928 A MX 2022013928A MX 2022013928 A MX2022013928 A MX 2022013928A MX 2022013928 A MX2022013928 A MX 2022013928A
Authority
MX
Mexico
Prior art keywords
venting
measurement
flow rates
emissions
detection
Prior art date
Application number
MX2022013928A
Other languages
English (en)
Inventor
Michael Williams
Gerard M P Giblin
David T Macpherson
David R Witty
Osama Suleiman
Thierry Bonnaud
Richard Edwards
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of MX2022013928A publication Critical patent/MX2022013928A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • C07C65/10—Salicylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Volume Flow (AREA)
  • Exhaust Gas After Treatment (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)

Abstract

La invención hace referencia a un proceso novedoso para la elaboración de espiroderivados, en particular 7-metil-2-[4-metil-6-[4-(trifluorometil)-fenil]pirimidin-2-il]-1, 7-diazaespiro[4.4]nonan-6-ona, así como a intermedios novedosos para uso en dicho proceso, junto con procesos de elaboración de dichos intermedios.
MX2022013928A 2017-10-10 2020-07-13 Proceso de elaboracion de espiroderivados. MX2022013928A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762570269P 2017-10-10 2017-10-10

Publications (1)

Publication Number Publication Date
MX2022013928A true MX2022013928A (es) 2022-11-30

Family

ID=66100090

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020003821A MX2020003821A (es) 2017-10-10 2018-10-10 Proceso de elaboración de espiroderivados.
MX2022013928A MX2022013928A (es) 2017-10-10 2020-07-13 Proceso de elaboracion de espiroderivados.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2020003821A MX2020003821A (es) 2017-10-10 2018-10-10 Proceso de elaboración de espiroderivados.

Country Status (12)

Country Link
US (2) US11149039B2 (es)
EP (1) EP3694510A4 (es)
JP (1) JP2020536898A (es)
KR (1) KR20200068678A (es)
CN (1) CN111526874A (es)
AU (1) AU2018347349A1 (es)
CA (1) CA3077088A1 (es)
IL (1) IL273695A (es)
MA (1) MA50371A (es)
MX (2) MX2020003821A (es)
SG (1) SG11202002707VA (es)
WO (1) WO2019075073A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020536898A (ja) 2017-10-10 2020-12-17 バイオジェン インコーポレイテッド スピロ誘導体を調製するためのプロセス

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US814396A (en) 1905-05-22 1906-03-06 Joseph R Russell Burner for liquid fuel.
KR0178475B1 (ko) * 1995-09-14 1999-03-20 윤덕용 신규한 n-비닐락탐 유도체 및 그의 중합체
MXPA05000370A (es) 2002-07-05 2005-04-19 Targacept Inc Compuestos n-aril diazaespiraciclicos y metodos de preparacion y usos de los mismos.
US7501528B2 (en) * 2005-03-15 2009-03-10 Hoffmann-La Roche Inc. Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives
ATE472529T1 (de) 2005-10-10 2010-07-15 Glaxo Group Ltd Prolinamidderivate als natriumkanalmodulatoren
TW200730494A (en) 2005-10-10 2007-08-16 Glaxo Group Ltd Novel compounds
GB0520578D0 (en) 2005-10-10 2005-11-16 Glaxo Group Ltd Novel compounds
US8143306B2 (en) 2005-10-10 2012-03-27 Convergence Pharmaceuticals Limited Methods of treating bipolar disorders
TW200728258A (en) 2005-10-10 2007-08-01 Glaxo Group Ltd Novel compounds
CA2666143A1 (en) 2006-10-12 2008-04-17 Xenon Pharmaceuticals Inc. Spiro (furo [3, 2-c] pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain
MX2009003874A (es) 2006-10-12 2009-04-22 Xenon Pharmaceuticals Inc Derivados de espiro-oxindol triciclicos y sus usos como agentes terapeuticos.
GB0701366D0 (en) 2007-01-24 2007-03-07 Glaxo Group Ltd Novel pharmaceutical compositions
GB0701365D0 (en) 2007-01-24 2007-03-07 Glaxo Group Ltd Novel pharmaceutical compositions
WO2008090114A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
GB0706630D0 (en) 2007-04-04 2007-05-16 Glaxo Group Ltd Novel compounds
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
WO2011029762A1 (en) 2009-09-14 2011-03-17 Convergence Pharmaceuticals Limited Process for preparing alpha-carboxamide derivatives
US8618303B2 (en) * 2011-01-07 2013-12-31 Hoffmann-La Roche Inc. Pyrrolidine derivatives
CA2829170C (en) * 2011-04-26 2019-02-26 F. Hoffmann-La Roche Ag Ethynyl derivatives as positive allosteric modulators of the mglur5
GB201122113D0 (en) * 2011-12-22 2012-02-01 Convergence Pharmaceuticals Novel compounds
GB201209015D0 (en) 2012-05-22 2012-07-04 Convergence Pharmaceuticals Novel compounds
GB201209670D0 (en) 2012-05-31 2012-07-18 Convergence Pharmaceuticals Novel compounds
HUE042064T2 (hu) * 2014-08-04 2019-06-28 Merck Patent Gmbh Pirrolidinon-származékok MetAP-2 inhibitorokként
US20200255438A1 (en) 2017-09-28 2020-08-13 Biogen Inc. Novel salts
JP2020536898A (ja) 2017-10-10 2020-12-17 バイオジェン インコーポレイテッド スピロ誘導体を調製するためのプロセス

Also Published As

Publication number Publication date
IL273695A (en) 2020-05-31
WO2019075073A2 (en) 2019-04-18
US20200325144A1 (en) 2020-10-15
EP3694510A4 (en) 2021-06-30
MX2020003821A (es) 2023-01-12
WO2019075073A3 (en) 2020-04-02
JP2020536898A (ja) 2020-12-17
CA3077088A1 (en) 2019-04-18
MA50371A (fr) 2021-03-31
CN111526874A (zh) 2020-08-11
EP3694510A2 (en) 2020-08-19
US20220033408A1 (en) 2022-02-03
KR20200068678A (ko) 2020-06-15
AU2018347349A1 (en) 2020-04-23
SG11202002707VA (en) 2020-04-29
US11149039B2 (en) 2021-10-19

Similar Documents

Publication Publication Date Title
MX2022013913A (es) Medidor de gas y metodos asociados.
WO2016046539A3 (en) Powder container and systems therewith
MY190532A (en) Method of pressure testing
GB2540523A (en) Wellbore systems with hydrocarbon leak detection apparatus and methods
GB2583275A8 (en) Methods and systems for monitoring drilling fluid rheological characteristics
WO2014052140A3 (en) Remote seal process pressure measuring system
FR3066119B1 (fr) Systeme et procede de suivi de la consommation de gaz d'un patient
NZ630446A (en) Monitoring systems and methods
SA517382146B1 (ar) مراقبة التدفق الكتلي وقياس الغازات
EA200900833A1 (ru) Устройство для отсечки текучей среды и газовый счетчик с устройством для отсечки текучей среды
MX2010007520A (es) Prueba zonal con el uso de tuberia continua.
GB2532149A (en) Multi-zone completion systems and methods
WO2012107727A3 (en) Well testing and production apparatus and method
WO2014147418A3 (en) Water deluge system testing apparatus and method
WO2014066430A3 (en) Method and system for identifying a self-sustained influx of formation fluids into a wellbore
EP2910730A3 (en) Systems and methods for locally performing well testing
MX2016007733A (es) Determinacion de porosidad efectiva para formaciones de gas compacto.
SA519401666B1 (ar) طرق وأنظمة لأخذ عينة من مائع و/أو تحليله
CA2615229A1 (en) Method and apparatus for utilizing pressure signature in conjunction with fall time as indicator in oil and gas wells
SA517381323B1 (ar) استخدام بيانات ضغط في الوقت الفعلي لتقييم أداء التصديع
WO2016022069A3 (en) Safety device and method
MY176604A (en) Method and apparatus for subsea well plug and abandonment operations
MX2022013928A (es) Proceso de elaboracion de espiroderivados.
ZA202104745B (en) Devices, methods, and systems for collection of volatile organic compounds
MX2016011287A (es) Metodo y dispositivo para estudio y control de yacimientos.